Results 81 to 90 of about 3,726 (164)

Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction. [PDF]

open access: yesNat Commun, 2023
Sülzen H   +12 more
europepmc   +1 more source

The epidemiological importance of the animal reservoir of Trypanosoma brucei gambiense in the Congo. 2. Characterization of the Trypanosoma brucei complex.

open access: yesTropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ), 1989
info:eu-repo/semantics ...
/Noireau, François   +7 more
openaire   +3 more sources

Control of sleeping sickness due to Trypanosoma brucei gambiense.

open access: yesBulletin of the World Health Organization, 1983
Sleeping sickness due to Trypanosoma brucei gambiense is endemic in 23 African countries and an estimated 45 million people are exposed to infection. The relatively low incidence of the disease (about 10 000 new cases each year) is mainly a result of 50 years of regular medical surveillance and treatment in combination with tsetse control where ...
openaire   +2 more sources

Target product profile: <i>Trypanosoma brucei gambiense</i> test for low-prevalence settings. [PDF]

open access: yesBull World Health Organ, 2023
Priotto G   +14 more
europepmc   +1 more source

Deep kinetoplast genome analyses result in a novel molecular assay for detecting Trypanosoma brucei gambiense-specific minicircles. [PDF]

open access: yesNAR Genom Bioinform, 2022
Geerts M   +7 more
europepmc   +1 more source

Experimental evidence that immune trypanolysis using the LiTat 1.3 and LiTat 1.5 variant antigen types is not specific to Trypanosoma brucei gambiense in pigs. [PDF]

open access: yesParasite, 2022
Ilboudo K   +14 more
europepmc   +1 more source

The effect of livestock density on Trypanosoma brucei gambiense and T. b. rhodesiense: A causal inference-based approach. [PDF]

open access: yesPLoS Negl Trop Dis, 2022
Meisner J   +9 more
europepmc   +1 more source

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. [PDF]

open access: yesLancet Infect Dis, 2023
Betu Kumeso VK   +30 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy